Bone Biologics Corp Warrants
BBLGW
About: Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Employees: 2
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
0% more funds holding
Funds holding: 3 [Q1] → 3 (+0) [Q2]
0.12% less ownership
Funds ownership: 1.22% [Q1] → 1.1% (-0.12%) [Q2]
4% less capital invested
Capital invested by funds: $557K [Q1] → $537K (-$20.3K) [Q2]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Financial journalist opinion
We haven’t received any recent news articles for BBLGW